(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

XYDRII

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

XYDRII

ST13

US500000079284840

Class

5

Filing

79284840

Registration

6192259

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

32

Latest update

11/11/2025

Trademark type

Word

Nice classes

5

Filing date

03/16/2020

Registration date

11/10/2020

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

11/10/2020

Last transaction

11/11/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

77

Owner location

IE

Examiner

SCLEIDOROVICH,JOANNA YAEL

Law office

O10

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Bausch + Lomb Ireland Limited
NOVARTIS AG

Representatives

Nancy L. Rowe Bausch + Lomb

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune systemthe metabolic systemthe endocrine systemthe musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma; all of the foregoing excluding pharmaceutical preparations for the treatment or prevention of neurological disorderssleep disorderscentral nervous system

Publications

History of USPTO decisions and trademark events.

32 publications found

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

11/10/2025

CHLD

CHANGE OF OWNER RECEIVED FROM IB

05/10/2024

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

03/17/2024

EWOR

TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED

03/17/2024

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

03/17/2024

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

03/17/2024

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

03/17/2024

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

03/17/2024

GPNX

NOTIFICATION PROCESSED BY IB

01/08/2021

FICS

FINAL DISPOSITION NOTICE SENT TO IB

12/18/2020

FIMP

FINAL DISPOSITION PROCESSED

12/17/2020

GPAR

GRANT OF PROTECTION CREATED, TO BE SENT TO IB

12/10/2020

R.PR

REGISTERED-PRINCIPAL REGISTER

11/10/2020

CHPB

POST PUBLICATION AMENDMENT - ENTERED

10/08/2020

APET

ASSIGNED TO PETITION STAFF

10/06/2020

ETOP

EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED

09/09/2020

EPPA

TEAS POST PUBLICATION AMENDMENT RECEIVED

08/18/2020

ETOF

EXTENSION OF TIME TO OPPOSE RECEIVED

07/30/2020

PUBO

PUBLISHED FOR OPPOSITION

06/30/2020

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

06/29/2020

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

06/29/2020

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

06/29/2020

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

06/29/2020

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

06/29/2020

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

06/29/2020

NPUB

NOTICE OF PUBLICATION

06/10/2020

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

05/28/2020

DOCK

ASSIGNED TO EXAMINER

05/27/2020

MAFR

APPLICATION FILING RECEIPT MAILED

05/15/2020

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

05/11/2020

LIMI

LIMITATION FROM ORIGINAL APPLICATION ENTERED

05/08/2020

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

05/07/2020

Continuous trademark protection

Get notified about every new filing that threatens XYDRII or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.